AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
55,000
Employees55,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
55,000
Employees55,000

ABBV Key Statistics

Market cap
410.02B
Market cap410.02B
Price-Earnings ratio
109.25
Price-Earnings ratio109.25
Dividend yield
2.82%
Dividend yield2.82%
Average volume
5.46M
Average volume5.46M
High today
$232.46
High today$232.46
Low today
$229.15
Low today$229.15
Open price
$230.75
Open price$230.75
Volume
4.84M
Volume4.84M
52 Week high
$244.81
52 Week high$244.81
52 Week low
$163.81
52 Week low$163.81

ABBV News

Nasdaq 12h
AbbVie's RINVOQ Outperforms HUMIRA In Head-to-Head Rheumatoid Arthritis Study

(RTTNews) - AbbVie Inc. (ABBV), Monday reported positive topline results from its Phase 3b/4 SELECT-SWITCH study comparing upadacitinib 15 mg once daily with ad...

TipRanks 17h
AbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study

AbbVie (ABBV) announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety of upadacitinib 15 mg,...

Nasdaq 1d
Guru Fundamental Report for ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model ba...

Guru Fundamental Report for ABBV

Analyst ratings

61%

of 31 ratings
Buy
61.3%
Hold
35.5%
Sell
3.2%

More ABBV News

TipRanks 3d
Schwab US Dividend Equity ETF Sees Negative Fund Flows

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 0.60% in the past week. It has experienced a 5-day net outflow of $224.35 million. This is due, in part, t...

Simply Wall St 3d
Is RINVOQ's New FDA Approval Changing the Long-Term Growth Story for AbbVie?

Earlier this month, AbbVie announced that the FDA approved an expanded indication for RINVOQ® (upadacitinib), allowing broader use in adult patients with modera...

Is RINVOQ's New FDA Approval Changing the Long-Term Growth Story for AbbVie?
Seeking Alpha 4d
AbbVie ends in green six straight sessions of declines

AbbVie (NYSE:ABBV) snapped six consecutive sessions of losses on Thursday as the stock ended 0.29% lower at $226.87. Since October 8, the stock has closed in t...

AbbVie ends in green six straight sessions of declines
TipRanks 5d
AbbVie’s Phase 2 Study on CLL/SLL Treatment: Key Updates and Market Impact

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

TipRanks 5d
AbbVie’s Venetoclax Study Completion: A Potential Boost for Investors

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

The Motley Fool 5d
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

Investors should be able to count on these stocks to deliver steady and growing income over the long term. The idea of steady money flowing in, year after year...

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Simply Wall St 6d
What AbbVie’s Bretisilocin Acquisition Means for Its Share Price in 2025

If you are staring at AbbVie's share price and wondering whether now is the right time to buy or hold, you are definitely not alone. AbbVie has been making plen...

What AbbVie’s Bretisilocin Acquisition Means for Its Share Price in 2025

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.